Zobrazeno 1 - 10
of 689
pro vyhledávání: '"D. Shouval"'
Autor:
N Tal-Shifman, C Tzivinikos, M Gasparetto, D E Serban, E Zifman, I Hojsak, O Ledder, A Yerushalmy Feler, H Rolandsdotter, M Aloi, M Bramuzzo, S Buderus, P Lionetti, L Norsa, C Norden, D Urlep, C Romano, R Shaoul, C Martinez-Vinson, A Karoliny, G Veereman, B Kang, E Vlčková, P Alvisi, M Kori, M Tavares, B Weiss, S Hussey, M Essen Qamhawi, L M Palomino Pérez, P Henderson, R Parmar, E Miele, F Firas Rinawi, A Lonzano-Ruf, V Zamvar, K L Kolho, D Shouval
Publikováno v:
Journal of Crohn's and Colitis. 17:i309-i311
Background Ulcerative proctitis (UP) is an uncommon presentation in paediatric patients with ulcerative colitis, accounting for Methods A retrospective cohort study involving 37 sites affiliated with the IBD Interest group of ESPGHAN. Data were colle
Autor:
C Fidalgo, A Walsh, M Adamina, M Barreiro-Acosta, J Burisch, D Drobne, O Faiz, M Ferrante, L Godny, M Iacucci, S Jäghult, S Restellini, F Rosini, D Shouval, H Yanai, G Fiorino
Publikováno v:
Journal of Crohn's and Colitis. 17:i26-i27
Background Recently, the European Crohn’s and Colitis Organisation (ECCO) Consensus on Quality-of-Care (QoC) Standards proposed essential criteria on the structure of units who manage patients with inflammatory bowel disease (IBD)1. The E-QUALITY t
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
O Ledder, M Dubinsky, M Dolinger, A Fatima, D Suskind, J Scarlett, D Röeser, D Shouval, G Meyer, Z Molle Rios, G Pujol, A Lozano, K L Kolho, P Rohani, S Hussey, T de Mejj, T Ayers, V M Navas López, D Turner, C Tzivinikos, R Stein, S Savla
Publikováno v:
Journal of Crohn's and Colitis. 17:i758-i758
Background Tofacitinib, a Janus kinase (JAK) inhibitor, has recently been approved for treatment of moderate to severe active ulcerative colitis (UC) in adults. Data on efficacy and safety in pediatrics are limited. In this multicenter study from the
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Z Shavit, R Stein, M Aloi, O Ledder, G Focht, D Urlep, J Hyams, E Broide, B Vais, J Levine, D Shouval, M Matar, A Assa, J Rosh, S Hussey, J Markowitz, A Yerushalmy-Feler, E Miele, R Shaoul, R K Russell, D Turner
Publikováno v:
Journal of Crohn's and Colitis. 16:i005-i006
Background Limited data are available on the use of Vedolizumab (VDZ) in paediatric Crohn’s Disease (CD) and Ulcerative Colitis (UC). We evaluated the effectiveness and safety of VDZ to induce remission at week 14 in the prospective, multicenter VE
Publikováno v:
Journal of Crohn's and Colitis. 16:i196-i197
Background Although Crohn’s disease (CD) is associated with a marked hyper-inflammatory response, identifying serum biomarkers associated with disease activity and outcomes is considered challenging, given lack of sensitivity of different assays. O
Autor:
A Guz Mark, M Aloi, L Scarallo, M Bramuzzo, J C Escher, P Alvisi, P Henderson, I Hojsak, R Lev-Tzion, W El-Matary, T Schwerd, B Weiss, M Sladek, C Strisciuglio, K Müller, C Olbjørn, C Tzivinikos, A Yerushalmy-Feler, A Christiaens, L Norsa, I Viola, L de Ridder, D Shouval, S Lega, P Lionetti, G Catassi, A Assa
Publikováno v:
Journal of Crohn's and Colitis. 16:i112-i113
Background Very early-onset inflammatory bowel disease (VEOIBD) is diagnosed before the age of 6 years while infantile IBD occurs before the age of 2 years. We aimed to assess disease characteristics and long-term outcomes in these populations. Metho
Autor:
B Ungar, M Yavzori, E Fudim, O Picard, U Kopylov, R Eliakim, D Shouval, Y Levin, A Savidor, S Ben-Moshe, R Manco, S Dan, A Egozi, K Bahar Halpern, C Mayer, I Barshak, S Ben-Horin, S Itzkovitz
Publikováno v:
Journal of Crohn's and Colitis. 16:i152-i153
Background Colonoscopy is the gold standard for evaluation of inflammation in inflammatory bowel diseases (IBD), yet entails cumbersome preparations and risks of injury. Existing non-invasive prognostic tools are limited in their diagnostic power. Mo